Gribbles Pathology, Malaysia’s largest private independent diagnostic laboratory services provider, announced its rebranding to Innoquest, as well as expanded offerings, including the latest testing capabilities, a state-of-the-art IT support system and a larger global network of medical expertise.
With the rebranding, the Malaysian entities are now aligned with the global brand of Innoquest, all under the Pathology Asia Holdings Group of clinical labs – an in-vitro diagnostic test provider with a strong presence in Singapore, Malaysia, Vietnam, Philippines, Australia and Indonesia. The Innoquest brand in Malaysia will be held under Innoquest Pathology Sdn Bhd.
Innoquest Pathology claims that it is the only multidisciplinary clinical laboratory in Malaysia to hold both College of American Pathology (CAP) and MS ISO15189 accreditations, reinforcing its best-in-class standards, services, and laboratory practices.
The enhanced IT infrastructure that integrates all lab-related activities will provide a seamless experience for medical professionals and patients.
BioMark, a proprietary end-to-end platform, will connect Innoquest’s laboratories with healthcare providers, patients and third-party stakeholders to provide digitalised ordering and processing of tests, real-time access to test results and remote patient monitoring via comprehensive electronic records.
“The decision to rebrand to Innoquest is an important one, and showcases our continued commitment to fast, reliable, accessible and best-in-class services,” said Dr Nelson Nheu, CEO of Innoquest Pathology.
“The last two years have demonstrated a need for a robust response to new developments in the global health landscape.
“Being a part of this strong regional network ensures that Innoquest Pathology is equipped with novel technologies, wider expertise in clinical laboratory practices and the capability to respond quickly and effectively, to improve its overall service delivery as a leading global diagnostics hub.”
Formerly known as Gribbles Pathology, the diagnostics lab merged with Quantum Diagnostics in 2019 and Clinipath Malaysia in 2021. Innoquest Pathology now has the scale advantage, resources, and professionals to offer high-quality and affordable testing services to our healthcare providers.
